Cargando…

ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: An Independent Analysis of Protocol i Study Data

PURPOSE: This post hoc analysis explores the relationship between early retinal anatomical response and long-term anatomical and visual outcomes with ranibizumab in center-involved diabetic macular edema. METHODS: Eyes randomized to the ranibizumab plus prompt laser and ranibizumab plus deferred las...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dugel, Pravin U., Campbell, Joanna H., Kiss, Szilárd, Loewenstein, Anat, Shih, Vanessa, Xu, Xiaoshu, Holekamp, Nancy M., Augustin, Albert J., Ho, Allen C., Gonzalez, Victor H., Whitcup, Scott M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Retina 2019
Materias:	Original Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325771/ https://www.ncbi.nlm.nih.gov/pubmed/29474302 http://dx.doi.org/10.1097/IAE.0000000000002110

Ejemplares similares

Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I data
por: Sadda, Srinivas R., et al.
Publicado: (2019)

Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel, Pravin U, et al.
Publicado: (2015)

Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema
por: Kiss, Szilárd, et al.
Publicado: (2014)

Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema
por: Kiss, Szilárd, et al.
Publicado: (2016)

Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study
por: Augustin, Albert J., et al.
Publicado: (2015)

Combination Therapy for Diabetic Macular Edema
por: Zur, Dinah, et al.
Publicado: (2012)

Pharmacology of Corticosteroids for Diabetic Macular Edema
por: Whitcup, Scott M., et al.
Publicado: (2018)

INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: Pharmacokinetic Considerations
por: Yang, Yit, et al.
Publicado: (2015)

CLINICAL EVIDENCE OF THE MULTIFACTORIAL NATURE OF DIABETIC MACULAR EDEMA
por: Chakravarthy, Usha, et al.
Publicado: (2018)

GRAding of functional and anatomical response to DExamethasone implant in patients with Diabetic Macular Edema: GRADE-DME Study
por: Rodríguez-Valdés, Patricio J., et al.
Publicado: (2021)

Biomarkers and predictors for functional and anatomic outcomes for small gauge pars plana vitrectomy and peeling of the internal limiting membrane in naïve diabetic macular edema: The VITAL Study
por: Iglicki, Matias, et al.
Publicado: (2018)

Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2)
por: Jumper, J Michael, et al.
Publicado: (2018)

Anatomical and functional correlates of cystic macular edema in retinitis pigmentosa
por: Ruff, Adam, et al.
Publicado: (2022)

Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema
por: Dugel, Pravin U., et al.
Publicado: (2021)

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)
por: Blinder, Kevin J, et al.
Publicado: (2017)

Phase 1 Study of THR-687, a Novel, Highly Potent Integrin Antagonist for the Treatment of Diabetic Macular Edema
por: Khanani, Arshad M., et al.
Publicado: (2021)

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials
por: Dugel, Pravin U, et al.
Publicado: (2016)

Real-World Injection Frequency and Cost of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
por: Kiss, Szilárd, et al.
Publicado: (2020)

Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration
por: Ho, Allen C., et al.
Publicado: (2021)

Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis
por: Kiss, Szilárd, et al.
Publicado: (2018)

Early detection of age related macular degeneration: current status
por: Schwartz, Roy, et al.
Publicado: (2015)

Intravitreal diclofenac versus intravitreal bevacizumab in persistent diabetic macular edema: Anatomical and functional outcome
por: ElBendary, Amal, et al.
Publicado: (2018)

Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases
por: Lanzetta, Paolo, et al.
Publicado: (2017)

Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion
por: Ryder, Steven J, et al.
Publicado: (2015)

Drivers of and Barriers to Adherence to Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treatment Management Plans: A Multi-National Qualitative Study
por: Giocanti-Aurégan, Audrey, et al.
Publicado: (2022)

Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis
por: Matas, Jessica, et al.
Publicado: (2019)

Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials
por: Danis, Ronald P, et al.
Publicado: (2016)

Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration
por: Moisseiev, Elad, et al.
Publicado: (2010)

When is macular edema not macular edema? An update on macular telangiectasia type 2
por: Wu, Lihteh
Publicado: (2015)

Costs and Quality of Life in Diabetic Macular Edema: Canadian Burden of Diabetic Macular Edema Observational Study (C-REALITY)
por: Gonder, John R., et al.
Publicado: (2014)

Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study
por: Singer, Michael A, et al.
Publicado: (2015)

Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study
por: Dugel, Pravin U., et al.
Publicado: (2015)

Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis
por: Souied, Eric H., et al.
Publicado: (2016)

Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema
por: Gelfman, Claire M., et al.
Publicado: (2021)

Prognostic Factors for Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Dexamethasone Implant
por: Lee, Hyungwoo, et al.
Publicado: (2018)

Systemic Regulatory T Cells and IL-6 as Prognostic Factors for Anatomical Improvement of Uveitic Macular Edema
por: Matas, Jessica, et al.
Publicado: (2020)

Optical Coherence Tomography Angiography Biomarkers Predict Anatomical Response to Bevacizumab in Diabetic Macular Edema
por: Elnahry, Ayman G, et al.
Publicado: (2022)

Ziv-aflibercept in Diabetic Macular Edema: Relation of Subfoveal Choroidal Thickness with Visual and Anatomical Outcomes
por: Moradian, Siamak, et al.
Publicado: (2023)

Cystoid macular edema
por: Rotsos, Tryfon G, et al.
Publicado: (2008)

Diabetic Macular Edema
por: Gundogan, Fatih C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cg961nhjjufo0dtoigm1m0hcnk